Building with Biology
What if we could grow everything?
Nature offers tantalizing examples of the magical properties of biology–self-assembly, self-repair, self-replication and more.
But perhaps the most astonishing feature of biology is that it runs on digital code in the form of DNA, which makes it possible for us to imagine building such living machines. The code is made up of A’s, T’s, C’s, and G’s, and we can read and write it to program cells like we program computers. If you’re passionate about engineering with biology, please join us!
Where fermentation is already used in bioindustrial applications, organism engineering can improve efficiency and sustainability of existing strains.
Enzymes are used in applications from cheesemaking to pharmaceuticals to stonewashed jeans. We’re discovering better enzymes for more applications.
New Product Development
We’re using yeast to produce cultured ingredients at scale not currently in a company portfolio, or that are sourced from expensive, unpredictable plant-based supply chains.
Making biology easier to engineer means we also have to make biology safer to engineer, too. We’re helping to develop software, diagnostics, vaccines, and other therapeutics against emerging threats and challenges, like COVID-19.
Mammalian Cell Engineering
We’re building a high-throughput process for the engineering of mammalian cell genomes, enabling a wide range of industrial and pharmaceutical applications.
The interesting thing to program in the 21st century isn’t going to be computers – it’s biology.
TOM KNIGHT | FOUNDER
Jason Kelly is the co-founder and CEO of Ginkgo Bioworks. He has served as a member of our board of directors since Ginkgo’s founding in 2008. He has also served as a director of CM Life Sciences II Inc. (Nasdaq: CMII), a special purpose acquisition company with a focus on the life sciences sector, since its initial public offering in February 2021. Dr. Kelly has a Ph.D. in Biological Engineering and a B.S. in Chemical Engineering and Biology from the Massachusetts Institute of Technology.
Reshma Shetty co-founded Ginkgo Bioworks in 2008. As President, Chief Operations Officer, and member of our board of directors, she has seen the company grow to over 500 people. Reshma has been active in the field of synthetic biology for 15+ years, and in 2006, she was an advisor to the iGEM competition where she was best known for engineering bacteria to smell like bananas and mint. Forbes magazine named Reshma one of 2008’s Eight People Inventing the Future, and Fast Company named her one of 100 Most Creative People in Business in 2011. Dr. Shetty has a B.S. degree in Computer Science from the University of Utah and a Ph.D. in Biological Engineering from MIT.
Barry is responsible for overall foundry technology strategy and direction. He holds a PhD in Biological Engineering from MIT, where his thesis focused on refinement of standard biological parts and the interactions between a host cell and an engineered genetic circuit. At MIT, he was involved with the Synthetic Biology Working Group that was instrumental in catalyzing the new field. He also holds an MEngSc in Mechanical Engineering from University College Dublin.
Austin is currently focused on strategic partnerships, investments, and expanding the Ginkgo ecosystem by working with non-traditional customers. He previously led software development at Ginkgo and built out a number of functions including the finance, people ops, IT, and infrastructure teams. He received his Ph.D. in Electrical Engineering and Computer Science from MIT working in the nascent field of synthetic biology. He also has a B.S. in Computer Science and A.B. in Psychology from Stanford University where he was awarded the departmental best honors thesis.